Literature DB >> 22156364

Inhibition of membrane Na+ channels by A type botulinum toxin at femtomolar concentrations in central and peripheral neurons.

Min-Chul Shin1, Masahito Wakita, Du-Jie Xie, Toshitaka Yamaga, Satomi Iwata, Yasushi Torii, Tetsuhiro Harakawa, Akihiro Ginnaga, Shunji Kozaki, Norio Akaike.   

Abstract

Recent studies have demonstrated that the botulinum neurotoxins inhibit the release of acetylcholine, glutamate, GABA, and glycine in central nerve system (CNS) neurons. The Na(+) current (I(Na)) is of major interest because it acts as the trigger for many cellular functions such as transmission, secretion, contraction, and sensation. Thus, these observations raise the possibility that A type neurotoxin might also alter the I(Na) of neuronal excitable membrane. To test our idea, we examined the effects of A type neurotoxins on I(Na) of central and peripheral neurons. The neurotoxins in femtomolar to picomolar concentrations produced substantial decreases of the neuronal I(Na), but interestingly the current inhibition was saturated at about maximum 50% level of control I(Na). The inhibitory pattern in the concentration-response curve for the neurotoxins differed from tetrodotoxin (TTX), local anesthetic, and antiepileptic drugs that completely inhibited I(Na) in a concentration-dependent manner. We concluded that A type neurotoxins inhibited membrane Na(+)-channel activity in CNS neurons and that I(Na) of both TTX-sensitive and -insensitive peripheral dorsal ganglion cells were also inhibited similarly to a maximum 40% of the control by the neurotoxins. The results suggest evidently that A2NTX could be also used as a powerful drug in treating epilepsy and several types of pain.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22156364     DOI: 10.1254/jphs.11060fp

Source DB:  PubMed          Journal:  J Pharmacol Sci        ISSN: 1347-8613            Impact factor:   3.337


  14 in total

Review 1.  [Use of intracutaneous or subcutaneous botulinum toxin for postherpetic neuralgia].

Authors:  L Halb; B J Amann; H Bornemann-Cimenti
Journal:  Nervenarzt       Date:  2017-04       Impact factor: 1.214

Review 2.  Botulinum Toxin Treatment in Multiple Sclerosis-a Review.

Authors:  Yasaman Safarpour; Tahereh Mousavi; Bahman Jabbari
Journal:  Curr Treat Options Neurol       Date:  2017-08-17       Impact factor: 3.598

3.  Intranasal Delivery of Botulinum Neurotoxin A Protects against Hippocampal Neuron Death in the Lithium-Pilocarpine Rat Model.

Authors:  Zhi Huang; Yajun Lian; Yuan Chen; Shuang Li; Haifeng Zhang; Nanchang Xie; Yake Zheng; Shouyi Wu; Yuhan Wang; Wenchao Cheng; Qiaoman Zhang; Chengze Wang; Yinping Shi; Na Xie
Journal:  Neurochem Res       Date:  2019-03-14       Impact factor: 3.996

Review 4.  Treatment of Chronic Migraine with Focus on Botulinum Neurotoxins.

Authors:  Sara M Schaefer; Christopher H Gottschalk; Bahman Jabbari
Journal:  Toxins (Basel)       Date:  2015-07-14       Impact factor: 4.546

Review 5.  Botulinum Toxin for the Treatment of Neuropathic Pain.

Authors:  JungHyun Park; Hue Jung Park
Journal:  Toxins (Basel)       Date:  2017-08-24       Impact factor: 4.546

6.  Botulinum toxin A treatment for post-herpetic neuralgia: A systematic review and meta-analysis.

Authors:  Xin-Long Li; Xu Zeng; Shan Zeng; Hai-Ping He; Zhen Zeng; Li-Lei Peng; Li-Gang Chen
Journal:  Exp Ther Med       Date:  2019-12-09       Impact factor: 2.447

7.  Removal of toxin (tetrodotoxin) from puffer ovary by traditional fermentation.

Authors:  Kensaku Anraku; Kiku Nonaka; Toshitaka Yamaga; Takatoshi Yamamoto; Min-Chul Shin; Masahito Wakita; Ayaka Hamamoto; Norio Akaike
Journal:  Toxins (Basel)       Date:  2013-01-18       Impact factor: 4.546

8.  Incobotulinum Toxin-A Improves Post-Surgical and Post-Radiation Pain in Cancer Patients.

Authors:  Rezvan Rostami; Shivam Om Mittal; Reza Radmand; Bahman Jabbari
Journal:  Toxins (Basel)       Date:  2016-01-13       Impact factor: 4.546

9.  Botulinum toxin-A for the treatment of neuralgia: a systematic review and meta-analysis.

Authors:  Fan Meng; Ke Peng; Jian-Ping Yang; Fu-Hai Ji; Fan Xia; Xiao-Wen Meng
Journal:  J Pain Res       Date:  2018-10-12       Impact factor: 3.133

Review 10.  Mechanisms of Botulinum Toxin Type A Action on Pain.

Authors:  Ivica Matak; Kata Bölcskei; Lidija Bach-Rojecky; Zsuzsanna Helyes
Journal:  Toxins (Basel)       Date:  2019-08-05       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.